Original release date: January 22, 2025
Course Description
Head and neck pathology is challenging given the broad diversity of entities that are part of the functional (rather than simply theoretical) vocabulary at these sites. With the beta releases of the 5th editions of both the Head and Neck and Endocrine World Health Organization (WHO) Classifications of Tumors in 2022, several new concepts and entities have arisen and still remain challenging. Furthermore, since the publication of WHO 5th edition, several provisional entities and concepts have emerged making it difficult to adapt these new changes into practice. Through this course, the participants will learn diagnostic features, practical reporting, key prognostic, and theragnostic information for a variety of new and uncommon tumor types spanning several head and neck and endocrine sites.
This course is a collaboration between the North American Society of Head and Neck Pathology (NASHNP) and USCAP.
Target Audience
Practicing academic and community pathologists, and pathologists-in-training
Learning Objectives
Upon completion of this educational activity, learners will be able to:
- Recognize the key diagnostic features for the squamous cell carcinoma subtypes.
- Recognize key thyroid tumor subtypes with distinctive molecular and clinical correlates.
- Develop an algorithmic approach to key categories in the sinonasal tract, namely “small round blue cell tumor” and sinonasal glandular proliferation differential diagnosis.
- Recognize the key diagnostic features for the squamous cell carcinoma subtypes.
Continuing Medical Education
Items Included in the Purchase of this Course
-
Salivary Gland, Sinonasal Glandular and Miscellaneous Pathology – Raja R. Seethala, MD
-
Thyroid, Bone and Soft Tissue and Intraoperative Squamous Pathology – Nicole A. Cipriani, MD
-
Thyroid and Squamous Lesions – Doreen N. Palsgrove, MD
-
Salivary, Sinonasal Mesenchymal and Round Blue Cell Tumor Pathology – Justin A. Bishop, MD
Reviews
There are no reviews yet.